Cargando…

Cancer Antigen 125 during Pregnancy in Women without Ovarian Tumor Is Not Often Rising

OBJECTIVE: To determine the percentage of rising serum cancer antigen (CA-125) in singleton pregnant women whose ultrasonographical findings were normal. METHODS: Singleton pregnant women who received antenatal care at our institute with a normal ultrasonographical examination in their first and/or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amampai, Rattapon, Suprasert, Prapaporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902053/ https://www.ncbi.nlm.nih.gov/pubmed/29805450 http://dx.doi.org/10.1155/2018/8141583

Ejemplares similares

Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery
por: Rungoutok, Muangloei, et al.
Publicado: (2022)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
por: Jeerakornpassawat, Dhammapoj, et al.
Publicado: (2020)

Ovarian Carcinosarcoma and Its Association with Mature Cystic Teratoma and Primary Tubal Carcinoma
por: Rewsuwan, Sunida, et al.
Publicado: (2016)

Profiling the Expression and Prognostic Values of FYN, A Non-Receptor Tyrosine Kinase, in Different Histological Types of Epithelial Ovarian Cancer
por: Dankai, Wiyada, et al.
Publicado: (2023)

Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?
por: Parkash, Jasmita, et al.
Publicado: (2023)

How Business Ecosystems Rise (and Often Fall)
por: Reeves, Martin, et al.
Publicado: (2019)

Micturition symptoms in gynecologic cancer patients receiving paclitaxel and platinum-based chemotherapy regimen: a prospective study
por: Wudtisan, Jongpeeti, et al.
Publicado: (2023)

Prevalence of malnourishment and predictive factors associated with the nutritional status of gynecologic cancer patients undergoing chemotherapy: a cross-sectional analysis
por: Sanguanwongthong, Khemmanat, et al.
Publicado: (2022)

Comparison of Hypersensitivity Reactions to Carboplatin Retreatment in Gynecologic Cancer Patients between One and Two Hour Infusions: a Randomized Trial Study
por: Pornwattanakrilert, Weerawich, et al.
Publicado: (2017)

Primary signet ring cell carcinoma with neuroendocrine differentiation arising in mucinous borderline tumor of the ovary
por: Pongsuvareeyakul, Tip, et al.
Publicado: (2019)

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2023)

Clinicopathological Prognostic Factors Influencing Survival Outcomes of Vulvar Cancer
por: Muangchang, Monwanee, et al.
Publicado: (2021)

iPMI: Machine Learning-Aided Identification of Parametrial Invasion in Women with Early-Stage Cervical Cancer
por: Charoenkwan, Phasit, et al.
Publicado: (2021)

Treatment Outcomes of Patients with Squamous Cell Carcinoma of the Vulva: The Largest Series from a Tertiary Care Hospital
por: Meelapkij, Panida, et al.
Publicado: (2018)

Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection
por: Smith, Maria, et al.
Publicado: (2020)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Relationships of Ex-Vivo Drug Resistance Assay and Cytokine Production with Clinicopathological Features in the Primary Cell Culture of Thai Ovarian and Fallopian Tube Cancer Patients
por: Mon, May Thuu, et al.
Publicado: (2017)

Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study
por: Lorchaivej, Supakorn, et al.
Publicado: (2022)

Efficacy of Listening to Music on Pain Reduction during Colposcopy-Directed Cervical Biopsy: A Randomized, Controlled Trial
por: Pradit, Lalita, et al.
Publicado: (2022)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2020)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

The Clinical Outcome of Laparoscopic Surgery for Endometriosis on Pain, Ovarian Reserve, and Cancer Antigen 125 (CA-125): A Cohort Study
por: Sarbazi, Fereshte, et al.
Publicado: (2021)

Poorly Differentiated Thyroid Carcinoma Arising in Struma Ovarii
por: Khunamornpong, Surapan, et al.
Publicado: (2015)

Clear-Cell Mesothelioma of Uterine Corpus: Diagnostic Challenges in Intraoperative Frozen Sections
por: Pongsuvareeyakul, Tip, et al.
Publicado: (2023)

Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis
por: Shin, Kyung-Hwa, et al.
Publicado: (2020)

How often do women use non-drug treatment methods for psyschiatric symptoms during pregnancy and postpartum periods?
por: Yuvaci, Hilal Uslu, et al.
Publicado: (2019)

Prognostic Value of Tumor Budding in Early-Stage Cervical Adenocarcinomas
por: Satabongkoch, Nopporn, et al.
Publicado: (2017)

Pituitary incidentalomas - How often is too often?
por: Ferechide, Dumitru, et al.
Publicado: (2009)

Pituitary incidentalomas - How often is too often?
por: Carsote, Mara, et al.
Publicado: (2009)

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
por: Furrer, Daniela, et al.
Publicado: (2019)

Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors
por: Qin, Yuan-yuan, et al.
Publicado: (2018)

Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
por: Hu, Xiao, et al.
Publicado: (2022)

The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence
por: Niu, Lina, et al.
Publicado: (2023)

Pleural lipomatosis: An often-forgotten intrathoracic tumor
por: Worden, Cameron P., et al.
Publicado: (2020)

The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients
por: Muhammad, Syamel, et al.
Publicado: (2023)

Spatial and Temporal Analyses of Cervical Cancer Patients in Upper Northern Thailand
por: Thongsak, Natthapat, et al.
Publicado: (2016)

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation
por: Menon, U, et al.
Publicado: (1999)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Polycystic Ovarian Syndrome: An Autobiographical Case Report of an Often Overlooked Disorder
por: Patel, Vithi Hitendra
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bvnt642mmj3jmvtg1s6c5cukf7